Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
Clinical trial NCT02941926 · COMPLETED
Trial details
- NCT number
- NCT02941926
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2019-11-08
- Enrollment
- 3246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.